Ex vivo resuscitation and evaluation of hearts after 22 minutes of normothermic cardiac arrest [0.03%]
常温心脏停搏22分钟后的心脏体外复苏与评估
Stig Steen,Qiuming Liao,Audrius Pascevivius et al.
Stig Steen et al.
Objective: The aim was to resuscitate and evaluate hearts ex vivo after 22 minutes of cardiac arrest with the goal of increasing the number of usable hearts from controlled donation after circulatory death (cDCD). ...
Long-term adherence to flecainide as a rhythm control therapy in recurrent atrial fibrillation - a retrospective cohort study [0.03%]
氟卡尼长期作为阵发性房颤节律控制治疗的维持研究-回顾性队列研究
Alexander Siotis,Samuel Johansson,Claus Graff et al.
Alexander Siotis et al.
Background. Flecainide is a first-line rhythm control treatment for patients with atrial fibrillation (AF), however long-term treatment outcomes are understudied. Objective. To investigate associations of electro- (ECG) and echocardiographi...
The ESCAPER Study - exploring protective mechanisms against cardiovascular disease in subjects at high risk: Rationale, study protocol, and first results [0.03%]
高强度人群中的保护机制对心血管疾病的研究-探索、研究方案及初步结果(The ESCAPER Study)
Ola Ekström,Håkan Arheden,Anders Christensson et al.
Ola Ekström et al.
IntroductionThe ESCAPER project explores cardiovascular resilience in individuals who, despite a high-risk factor burden-longstanding Type 1 Diabetes (T1D), obesity, or kidney failure-avoid or delay macrovascular complications. This suggest...
Anna Albåge,Hans Granfeldt,Farkas Vánky
Anna Albåge
Objectives: In September 2019, the preferred surgical approach shifted for patients undergoing mitral valve (MV) surgery at our institution. The aim of this study was to compare minimally invasive surgery (MIS) with prior...
Matti Riihiniemi,Jarkko Piuhola,Matti Niemelä et al.
Matti Riihiniemi et al.
Background: Due to aging population, nonagenarians are increasingly undergoing percutaneous coronary intervention (PCI). However, the safety and efficacy of PCI in this elderly population remains somewhat unknown. ...
Outcomes following repair of acute type A aortic dissection in patients with cerebral malperfusion [0.03%]
急性A型主动脉夹层破裂患者的脑部缺血预处理效果分析
Jacob Ede,Karl Teurneau-Hermansson,Birgitta Ramgren et al.
Jacob Ede et al.
Objectives: Patients with acute type A aortic dissection (ATAAD) presenting with cerebral malperfusion have significantly poorer postoperative outcomes, making the decision whether to perform acute surgery difficult. The ...
Aortic Valve Phenotype and Distal Aortic Outcome after Ascending Aortic Surgery [0.03%]
根部主动脉手术后的主动脉瓣表型与远端主动脉结局的关系
Carl Granath,Michael Dismorr,Hanna M Björck et al.
Carl Granath et al.
Objectives: Recent guidelines advocate postoperative aortic surveillance without clear distinction between aortic valve phenotypes. We sought to determine the long-term occurrence and location of distal aortic complicatio...
Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation [0.03%]
经导管主动脉瓣植入术后永久起搏器植入的预测因素
Martin Petter Høydahl,Didrik Kjønås,Assami Rösner et al.
Martin Petter Høydahl et al.
PurposeTranscatheter aortic valve implantation (TAVI) is increasingly performed in patients with longer life expectancies. The need for permanent pacemaker implantation (PPI) following TAVI has been associated with increased all-cause morta...
Cardiogenic shock and extracorporeal membrane oxygenation: Etiology and 1-year survival [0.03%]
心源性休克和体外膜肺氧合：病因和一年生存率
Inga L Ingvarsdottir,Andreas Westerlind,Isabella Lepore et al.
Inga L Ingvarsdottir et al.
Objectives: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used to provide cardiorespiratory support in cardiogenic shock, but selection of patients and timing of ECMO-start remains a challenge. This study ...
Shrunken Pore Syndrome in heart transplantation; a pore ready to close? [0.03%]
心脏移植中的缩小孔隙综合症；一个即将关闭的孔隙？
Erik Herou,Emilie Mörtsell,Anders Grubb et al.
Erik Herou et al.
BackgroundA newly discovered renal syndrome, Shrunken Pore Syndrome (SPS), has been shown to increase mortality regardless of renal function. SPS is defined as an estimated glomerular filtration rate (eGFR) of cystatin C ≤ 60% than eGFRcre...